Harry Freeman

Harry Freeman has over 35 years of experience in the medical device industry, working for such companies as Compact Particle Acceleration Corporation (CPAC), TomoTherapy, Varian Medical Systems, Siemens Medical Systems, Philips Medical Systems and Landauer Medical Physics. Harry has sold over one billion dollars of capital equipment and services and has expertise in product development, technology evaluation, product introductions, operations, marketing and sales.

In 1990, Harry began their career in medical device industry with Siemens Healthcare as a Sales representative. Harry then moved to Varian Medical Systems in 2000, also as a Sales representative. In 2008, they joined TomoTherapy as a Director of Commercial Operations, North America, Director of Sales, North America, and Regional Sales Director. Later that year, they became the National Sales Director, Freestanding Business Development at Accuray. In 2012, they were appointed as the Chief Commercial Officer at CPAC. From 2014 to 2016, they held the roles of Regional Sales Director - Southwest and Director - National Accounts - Care Coordination at Equicare Health. In 2016, they were the Acting Chief Commercial Officer, Business Development & Commercialization Adviser at ProtonVDA, and the Senior Director of Business Development, Therapy Physics at Landauer Medical Physics. Harry is currently the Chief Commercial Officer for Leo Cancer Care.

Harry Freeman completed the NIH I-Corps SBIR & STTR program in 2016 and attended New York University in 1981.